期刊文献+

C-反应蛋白在HIV/AIDS的表达及其相关性研究 被引量:8

Expression of C-reactive protein in HIV/AIDS patients and relevant studies
原文传递
导出
摘要 目的探讨在抗病毒治疗前血清C-反应蛋白(CRP)在人类免疫缺陷病毒感染者/获得性免疫缺陷综合征患者(HIV/AIDS)中的表达及其与WHO临床分期的关系,为研究HIV疾病进展和预后提供理论依据。方法分别测定173例HIV/AIDS及24名健康对照组血清CRP水平,对WHO临床各期及健康对照组的CRP水平进行比较,分析CRP水平与WHO临床分期的相关性。结果 WHO临床I、Ⅱ、Ⅲ、Ⅳ期、健康对照组CRP水平分别为0.05、0.14、3.85、6.10、0mg/L,组间差异有统计学意义(P<0.05);WHO临床Ⅱ、Ⅲ、Ⅳ期CRP水平均分别高于健康对照组(P<0.05),WHO临床Ⅲ、ⅣCRP水平分别高于Ⅱ、Ⅰ期(P<0.05),WHO临床Ⅰ期CRP水平和Ⅱ期差异无统计学意义,WHO临床Ⅲ期CRP水平和Ⅳ期差异无统计学意义;CRP的表达与性别、年龄、CD4细胞、WHO临床分期、体质量指数、血清白蛋白、血红蛋白均相关(P<0.05);调整年龄、性别后,CRP同CD4细胞、体质量指数、血清白蛋白、血红蛋白呈负相关(P<0.05),同WHO临床分期呈正相关(P<0.05)。结论 CRP在HIV/AIDS中呈高表达,与疾病进展呈正相关。 OBJECTIVE To explore the expression of serum C-reactive protein (CRP) in the patients infected with human immunodeficiency virus (HIV) or the patients with acquired immunodeficiency syndrome (AIDS) before the antiviral therapy and study its correlation with the clinical staging of WHO so as to provide theoretical basis for the study of progression and outcome of the HIV infections. METHODS The levels of serum CRP were respectively determined for 173 cases of HIV/AIDS and 24 healthy people, then the clinical stages of WHO and the levels of serum CRP were observed and compared, and the correlation between the level of serum CRP and the clinical stag- ing was analyzed. RESULTS The level of serum CRP was 0.05 mg/L in the WHO stage Ⅰ, 0.14 mg/L in the WHO stage Ⅱ , 3.85 mg/L in the WHO stage Ⅲ , 6.10 mg/L in the WHO stage Ⅳ, 0 mg/L in the control group, the difference was statistically significant(P〈0.05) ; the levels of serum CRP were respectively higher in the WHO stage Ⅱ , Ⅲ, or Ⅳ than in the control group (all P〈0.05) ; the level of serum CRP in the WHO stage UI or Ⅳ was higher than that in the WHO stage Ⅱ or Ⅰ (all P〈0.05) ; the difference in the level of serum CRP between the WHO stage Ⅰ and the WHO stage Ⅱ was not statistically significant; the difference in the level of serum CRP between the WHO stage Ⅲ and the WHO stage IV was not statistically significant. The expression of CRP was re- lated to the gender, age, CD4 , WHO clinical staging, body mass index, serum albumin, and hemoglobin (all P〈 0.05) i after the age and gender were adjusted, the expression of CRP was negatively correlated with the CD4, body mass index, serum albumin, and hemoglobin (all P〈0.05) hut was positively correlated with the WHO clinical staging (P〈0.05). CONCLUSION The HIV/AIDS patients demonstrate a high expression of CRP, which is positively correlated with the progression of disease.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第2期271-273,共3页 Chinese Journal of Nosocomiology
基金 广西壮族自治区南宁市科学研究与技术开发计划基金项目(20123160)
关键词 人类免疫缺陷病毒 获得性免疫缺陷综合征 炎症反应 C-反应蛋白 艾滋病分期 Human immunodeficiency virus Acquired immunodeficiency syndrome Inflammatory response C-re-active protein Inflammation Clinical staging of AIDS
  • 相关文献

参考文献7

  • 1Redd AD,Eaton KP,Kong X. C-reactive protein levels increase during HIV-1 disease progression in Rakai,Uganda,despite the absence of microbial translocation[J].{H}Journal of Acquired Immune Deficiency Syndromes,2010,(05):556-559.
  • 2Boulware DR,Hullsiek KH,Puronen CE. Higher Levels of CRP,D-dimer,IL-6,and hyaluronic acid before initiation of antiretroviral therapy(ART) are associated with increased risk of AIDS or death[J].{H}Infectious Disease,2011,(11):1637-1646.
  • 3米术斌,张雷,段一娜,王英杰.SPSS软件进行随机区组设计非参数检验的多重比较[J].现代预防医学,2009,36(2):217-219. 被引量:14
  • 4Chaudhary M,Kashyap B,Gautam H. Role of C-Reactive Protein in HIV Infection:A Pilot Study[J].{H}Viral Immunology,2008,(02):253-266.
  • 5梁飞立,何艳英,余丰,苏齐鉴,何燕,方鹏,邓梅花.广西横县艾滋病抗病毒治疗早期生存情况及其影响因素分析[J].中华临床医师杂志(电子版),2012,6(17):5273-5275. 被引量:10
  • 6Neuhaus J,Jacobs DR Jr,Baker JV. Markers of Inflam mation,Coagulation and Renal Function Are Elevated in Adults with HIV Infection[J].{H}Journal of Infectious Diseases,2010,(12):1788-1795.
  • 7梁飞立,何艳英,黄绍标,邓梅花,招忠满,何燕.老年艾滋病31例抗病毒治疗的效果观察[J].广西医学,2012,34(11):1498-1500. 被引量:5

二级参考文献24

  • 1李韩平,刘伟,刘海霞,梁淑家,鲍作义,刘永建,庄道民,刘思扬,李林,李敬云.广西壮族自治区133例艾滋病患者抗病毒治疗效果评价[J].中华流行病学杂志,2007,28(4):338-342. 被引量:43
  • 2欧秋英,魏秀青,陈曦,覃莎莎,贺健梅,江洋.湖南省艾滋病抗病毒治疗死亡患者相关因素分析[J].实用预防医学,2007,14(3):672-673. 被引量:16
  • 3张文彤.SPSS11统计分析教程[M].北京:北京希望电子出版社,2002.21-24.
  • 4中华人民共和国卫生部,联合国艾滋病规划署,世界卫生组织.2011年中国艾滋病疫情估计[R].北京:卫生部,2011.
  • 5Nogueras M, Navarro G, Anton E, et al. Epidemiological and clinical features, response to HAART, and survival in HIV- infected patients diagnosed at the age of 50 or more [ J ]. BMC Infect Dis,2006,6 : 159.
  • 6Gebo KA, Justice A. HIV Infection in the elderly [ J ]. Curr Infect Dis Rep,2009,11(3) :246 -254.
  • 7WHO. Impact of AIDS on older people in Mrica Zimbabwe case study[ R]. 2002 : 12.
  • 8Zhang F, Dou Z, Ma Y, et al. Five year outcomes of the China national free antiretroviral treatment program [ J ]. Ann Intern Med,2009,151 (4) : 1 - 16.
  • 9Wellons MF, Sanders L, Edwards LJ, et al. HIV infection: treatment outcomes in older and younger adults [ J ]. J Am Geriatr Soc ,2002,50(4) :603 - 607.
  • 10ZhangF,DouZ,YuL. TheeffectofhighlyactiveantiretroviraltherapyonmortalityinHIV-InfectedformerplasmadonorsinChina[J].Clinical Infectious Diseases,2008.825-833.

共引文献26

同被引文献58

  • 1周宓,潘柏申.C-反应蛋白在临床应用中的进展[J].国外医学(临床生物化学与检验学分册),2005,26(1). 被引量:114
  • 2美国糖尿病学会(ADA).糖尿病诊断标准(四).国际内分泌代谢杂志,2006,:3-5.
  • 3中华医学会感染病学分会艾滋病学组.艾滋病诊疗指南(2011版)[J].中华传染病杂志,2011,29:629-640.
  • 4朱晓燕,刘书娟,刘宇健,等.糖皮质激素在炎症中的作用及其分泌调节[A]//中国生理学会第九届全国青年生理学工作者学术会议论文集[C].2011.
  • 5Lawn SD, Harries AD, Anglaret X, et al. Early mortality among adults accessing antiretroviral treatment programmes in sub- Saharan Africa[J]. AIDS,2008,22(15): 1897-1908.
  • 6Zhang F, Dou Z, Ma Y, et al. Five year outcomes of the China national free antiretroviral treatment program[J]. Ann Intern Med,2009,151 (4):241-251.
  • 7Boulware DR, Hullsiek KH, Puronen CE, et al. Higher levels of CRP, D-dimer, IL-6 and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or Death[J]. J Infect Dis,2011,203(11): 1637-1646.
  • 8Liovat AS, Rey-Cuille MA, Lecuroux C, et al. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV- 1 infection[J]. PLoS One,2012,7(10):e46143.
  • 9Nixon DE, Landay AL. Biomarkers of immune dysfunction in HIV[J]. Curr Olain HIV AIDS,2010,5(6):498-503.
  • 10Redd AD, Eaton KP, Kong X, et al. C-reactive protein levels increase during HIV-1 disease progression in Rakai, Uganda, despite the absence of microbial translocation[J]. J Acquir Immune Defic Syndr,2010,54(5):556-559.

引证文献8

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部